Skip to main content
SYRE logo

SYRE · Spyre Therapeutics, Inc.

$97.89 -2.08 (-2.08%)
Market Cap
$8.68B
Shares
86.84M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-07-01 CAMERON TURTLE 45,000
2026-06-25 SCOTT BURROWS 15,000
2026-06-23 Fairmount Healthcare Fund II L.P. 4,684,781
2026-06-22 MICHAEL HENDERSON 20,000
2026-06-03 SHELDON SLOAN 16,667
2026-05-08 MICHAEL HENDERSON 80,000
2026-05-01 SCOTT BURROWS 27,500
2026-05-01 SHELDON SLOAN 78,333
2026-04-01 SHELDON SLOAN 7,958
2026-03-03 SCOTT BURROWS 10,000
2026-03-02 CAMERON TURTLE 60,000
2025-11-03 CAMERON TURTLE 90,000
2024-10-25 SESSIONS, LLC 7,000
Showing 1–13 of 13 filings
Key facts CIK 1636282 CUSIP 00773J202 13F (30d) 22 filings 22 filers Visit website Investor relations